Further observations on an outbreak of diphenylhydantoin intoxication.
D001315:Australia; D002118:Calcium / Q000009:adverse effects; D002214:Capsules; D006801:Humans; D007785:Lactose / Q000009:adverse effects; D008274:Magnesium / Q000009:adverse effects; D009069:Movement Disorders / Q000139:chemically induced; D010592:Pharmaceutic Aids / Q000009:adverse effects*; D010672:Phenytoin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000506:poisoning*; D012822:Silicon Dioxide / Q000009:adverse effects; D013229:Stearic Acids / Q000009:adverse effects
D002214:Capsules; D010592:Pharmaceutic Aids; D013229:Stearic Acids; D010672:Phenytoin; D012822:Silicon Dioxide; D008274:Magnesium; D007785:Lactose; D002118:Calcium